跳至主要内容
临床试验/IRCT201410021556N65
IRCT201410021556N65已完成3 期

Simvastatine in the treatment of negetive symptoms in stable schizophrenia: a double blind and randomised clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Inclusion Criteria:1-Diagnosis of Schizophrenia based on DSM- 5 criteria;2- Minimum Score of 20 in negative subscale of Positive and Negative Scale(PANNS) 3- Age between 18-50; 4- chronic Schizophrenia- duration of the disorder more than 2 years; ;

排除标准

  • 1-any other mental disorder on axis I; 2-Any serious medical or neurological problem; 3- IQ less than 70; 4- Substance dependence(except for nicotine and caffeine); 5-receiving ECT during the last 14 days,6-Depression Score less than 12 in Hamilton depression scale

研究者

相似试验